According to Alnylam Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is โน294.77 Billion. In 2024 the company made a revenue of โน192.86 Billion an increase over the revenue in the year 2023 that were of โน152.20 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.